NovoCure LimitedNVCRNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+2.9%
5Y CAGR+11.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+2.9%/yr
vs +42.1%/yr prior
5Y CAGR
+11.2%/yr
Recent deceleration
Acceleration
-39.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$224.54M+7.1%
2024$209.65M-6.0%
2023$223.06M+8.2%
2022$206.09M+2.4%
2021$201.30M+52.5%
2020$132.01M+67.1%
2019$79.00M+56.2%
2018$50.57M+32.7%
2017$38.10M-8.1%
2016$41.47M-